The Cologuard Plus test is being offered as an in-network service to eligible Humana Medicare Advantage members.

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded ...

Seen and head at the Cologuard Classic: Cologuard ambassador Jerry Kelly (shoulder) forced to withdraw; improving weather; "Chloe the Giant Colon"; and more.

Shares of Humana Inc. (NYSE: HUM) are trading lower Friday after the company lost a legal battle over Medicare bonus payments.

Humana Inc. shares fell after it lost a lawsuit seeking to reverse cuts to its Medicare bonus payments, a blow for the insurer that had hoped the court would restore billions in revenue.

A federal judge in Texas on Friday tossed a lawsuit brought by Humana that challenged the U.S. government's reduction in the health insurer's star ratings for government-backed Medicare plans.

Humana Inc. shares fell after it lost a lawsuit seeking to reverse cuts to its Medicare bonus payments, a blow for the insurer that had hoped the court would restore billions in revenue.

By Nicholas G. Miller Humana lost its legal challenge to restore the quality ratings of its Medicare plans in a significant blow to future earnings potential.

Humana Inc (NYSE: HUM) has hit a 52-week low, with its stock price falling to 212.33 USD. This marks a significant downturn for the company, as it reflects a 42.31% decline over the past year.

Humana will release its 2 Q25 financial results, as well as prepared management remarks, at 6:00 a.m. Eastern time on July 30, 2025. A reconciliation of non-GAAP financial measures to financial ...

Humana lost its legal challenge to restore the quality ratings of its Medicare plans in a significant blow to future earnings potential. A Texas district court ruled Friday against Humana, saying ...

CMS denied an appeal from Humana over its star ratings scores, with the lawsuit's outcome yet to be determined.